ConductScience.org, home

Paper383261

Rationale and experimental design for the VA Cooperative Study of Anticoagulation (Warfarin) in the Treatment of Cancer.

Zacharski LR and 7 others. Cancer, 1979. Cited by 112 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Rationale and experimental design for the VA Cooperative Study of Anticoagulation (Warfarin) in the Treatment of Cancer. Papers, record 383261. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/383261

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Rationale and experimental design for the VA Cooperative Study of Anticoagulation (Warfarin) in the Treatment of Cancer.
PubMed
Journal
Cancer
PubMed
Year
1979
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article, Review
PubMed
Citations, by iCite
112
iCite
Relative citation ratio, by iCite
3.95
iCite
Revised in PubMed
2019-06-19
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zacharski LRL R
2Henderson WGW G
3Rickles FRF R
4Forman WBW B
5Cornell CJ JrC J
6Forcier RJR J
7Harrower HWH W
8Johnson ROR O

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Blood CoagulationMajor topic
Neoplasm MetastasisMajor topic
NeoplasmsMajor topic
Neoplastic Cells, CirculatingMajor topic
WarfarinMajor topic
Animals
Cell Adhesion
Clinical Trials as Topic
Female
Humans
Male
Neoplasms, Experimental
Research Design

Source PubMed

Download CSV of topics

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 112 citations.

PMIDTitleJournalYearIn PapersSource
37280670Tissue factor (coagulation factor III): a potential double-edge molecule to be targeted and re-targeted toward cancer.Biomark Res2023https://conductscience.org/library/papers/37280670PubMed
35860682Encephalomalacia/gliosis, deep venous thrombosis, and cancer in Arg393His antithrombin Hanoi and the potential impact of the β-amyloid precursor protein (APP) on thrombosis and cancer.AIMS Neurosci2022https://conductscience.org/library/papers/35860682PubMed
23420392Inhibition of MCF-7 breast cancer cell-induced platelet aggregation using a combination of antiplatelet drugs.Oncol Lett2013https://conductscience.org/library/papers/23420392PubMed
22084664Clinical use of the low-molecular-weight heparins in cancer patients: focus on the improved patient outcomes.Thrombosis2011https://conductscience.org/library/papers/22084664PubMed
7618230Theories on the metastatic process and possible therapeutic options.Urol Res1995https://conductscience.org/library/papers/7618230PubMed
7130245Anticoagulant treatment of rats with Walker 256 carcinosarcoma.J Cancer Res Clin Oncol1982https://conductscience.org/library/papers/7130245PubMed
7046453Fibrin deposits in Hodgkin's disease.Am J Pathol1982https://conductscience.org/library/papers/7046453PubMed
7027026Post-translational carboxylation of preprothrombin.Mol Cell Biochem1981https://conductscience.org/library/papers/7027026PubMed
6654954Levels of fibrinogen/fibrin degradation fragment E and related substances in sera and effusions of patients with malignant disease.J Cancer Res Clin Oncol1983https://conductscience.org/library/papers/6654954PubMed
6400436Involvement of a cathepsin B-like cysteine proteinase in platelet aggregation induced by tumor cells and their shed membrane vesicles.Clin Exp Metastasis1983https://conductscience.org/library/papers/6400436PubMed
6242706Inhibition of tumor cell metastasis by modulation of the vascular prostacyclin/thromboxane A2 system.Clin Exp Metastasis1983https://conductscience.org/library/papers/6242706PubMed
6206208Brain metastasis localized to an area of infarction.J Neurooncol1983https://conductscience.org/library/papers/6206208PubMed
6193869Fibrin as a component of the tumor stroma: origins and biological significance.Cancer Metastasis Rev1983https://conductscience.org/library/papers/6193869PubMed
3434341Metastatic brain tumour and fibrinopeptides.Acta Neurochir (Wien)1987https://conductscience.org/library/papers/3434341PubMed
3166906Promotion of metastasis by a specific complex of coagulation factors may be independent of fibrin formation.Br J Cancer1988https://conductscience.org/library/papers/3166906PubMed
2467397Abnormal haemostasis in small cell lung cancer.Thorax1988https://conductscience.org/library/papers/2467397PubMed
1465406Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis.Proc Natl Acad Sci U S A1992https://conductscience.org/library/papers/1465406PubMed
1423826Clinical trials with anticoagulant and antiplatelet therapies.Cancer Metastasis Rev1992https://conductscience.org/library/papers/1423826PubMed
1423819The role of fibrin in tumor metastasis.Cancer Metastasis Rev1992https://conductscience.org/library/papers/1423819PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/383261

GET https://conductscience.org/api/papers/v1/383261/authors